HEADER TRANSFERASE 06-AUG-09 3IL6
TITLE STRUCTURE OF E. FAECALIS FABH IN COMPLEX WITH 2-({4-[(3R,5S)-3,5-
TITLE 2 DIMETHYLPIPERIDIN-1-YL]-3-PHENOXYBENZOYL}AMINO)BENZOIC ACID
COMPND MOL_ID: 1;
COMPND 2 MOLECULE: 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE 3;
COMPND 3 CHAIN: A;
COMPND 4 SYNONYM: 3-OXOACYL-[ACYL-CARRIER-PROTEIN] SYNTHASE III, BETA-
COMPND 5 KETOACYL-ACP SYNTHASE III, KAS III;
COMPND 6 EC: 2.3.1.180;
COMPND 7 ENGINEERED: YES;
COMPND 8 MUTATION: YES
SOURCE MOL_ID: 1;
SOURCE 2 ORGANISM_SCIENTIFIC: ENTEROCOCCUS FAECALIS;
SOURCE 3 ORGANISM_TAXID: 1351;
SOURCE 4 GENE: EF_2885, FABH;
SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI;
SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562
KEYWDS FABH, FATTY ACID BIOSYNTHESIS, ANTIBIOTIC, ACYLTRANSFERASE,
KEYWDS 2 CYTOPLASM, LIPID SYNTHESIS, MULTIFUNCTIONAL ENZYME, TRANSFERASE
EXPDTA X-RAY DIFFRACTION
AUTHOR K.S.GAJIWALA,S.MARGOSIAK,J.LU,J.CORTEZ,Y.SU,Z.NIE,K.APPELT
REVDAT 5 20-NOV-24 3IL6 1 REMARK
REVDAT 4 06-SEP-23 3IL6 1 REMARK
REVDAT 3 13-OCT-21 3IL6 1 REMARK SEQADV LINK
REVDAT 2 06-OCT-09 3IL6 1 JRNL
REVDAT 1 25-AUG-09 3IL6 0
JRNL AUTH K.S.GAJIWALA,S.MARGOSIAK,J.LU,J.CORTEZ,Y.SU,Z.NIE,K.APPELT
JRNL TITL CRYSTAL STRUCTURES OF BACTERIAL FABH SUGGEST A MOLECULAR
JRNL TITL 2 BASIS FOR THE SUBSTRATE SPECIFICITY OF THE ENZYME.
JRNL REF FEBS LETT. V. 583 2939 2009
JRNL REFN ISSN 0014-5793
JRNL PMID 19665020
JRNL DOI 10.1016/J.FEBSLET.2009.08.001
REMARK 2
REMARK 2 RESOLUTION. 2.50 ANGSTROMS.
REMARK 3
REMARK 3 REFINEMENT.
REMARK 3 PROGRAM : CNX
REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE-
REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU,
REMARK 3 : READ,RICE,SIMONSON,WARREN,ACCELRYS
REMARK 3 : SOFTWARE INC.(BADGER,BERARD,KUMAR,SZALMA,
REMARK 3 : YIP,DZAKULA)
REMARK 3
REMARK 3 DATA USED IN REFINEMENT.
REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50
REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 24.36
REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000
REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 519487.020
REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000
REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 96.5
REMARK 3 NUMBER OF REFLECTIONS : 19129
REMARK 3
REMARK 3 FIT TO DATA USED IN REFINEMENT.
REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT
REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM
REMARK 3 R VALUE (WORKING + TEST SET) : 0.190
REMARK 3 R VALUE (WORKING SET) : 0.185
REMARK 3 FREE R VALUE : 0.219
REMARK 3 FREE R VALUE TEST SET SIZE (%) : 9.800
REMARK 3 FREE R VALUE TEST SET COUNT : 1874
REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.005
REMARK 3
REMARK 3 FIT/AGREEMENT OF MODEL WITH ALL DATA.
REMARK 3 R VALUE (WORKING + TEST SET, NO CUTOFF) : NULL
REMARK 3 R VALUE (WORKING SET, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET SIZE (%, NO CUTOFF) : NULL
REMARK 3 FREE R VALUE TEST SET COUNT (NO CUTOFF) : NULL
REMARK 3 ESTIMATED ERROR OF FREE R VALUE (NO CUTOFF) : NULL
REMARK 3 TOTAL NUMBER OF REFLECTIONS (NO CUTOFF) : 20488
REMARK 3
REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN.
REMARK 3 TOTAL NUMBER OF BINS USED : 6
REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.50
REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.66
REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 91.30
REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2713
REMARK 3 BIN R VALUE (WORKING SET) : 0.2290
REMARK 3 BIN FREE R VALUE : 0.2680
REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 9.50
REMARK 3 BIN FREE R VALUE TEST SET COUNT : 285
REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.016
REMARK 3
REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT.
REMARK 3 PROTEIN ATOMS : 2460
REMARK 3 NUCLEIC ACID ATOMS : 0
REMARK 3 HETEROGEN ATOMS : 63
REMARK 3 SOLVENT ATOMS : 112
REMARK 3
REMARK 3 B VALUES.
REMARK 3 FROM WILSON PLOT (A**2) : 39.70
REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.60
REMARK 3 OVERALL ANISOTROPIC B VALUE.
REMARK 3 B11 (A**2) : -8.12000
REMARK 3 B22 (A**2) : -8.12000
REMARK 3 B33 (A**2) : 16.25000
REMARK 3 B12 (A**2) : 0.89000
REMARK 3 B13 (A**2) : 0.00000
REMARK 3 B23 (A**2) : 0.00000
REMARK 3
REMARK 3 ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.26
REMARK 3 ESD FROM SIGMAA (A) : 0.24
REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00
REMARK 3
REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR.
REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.31
REMARK 3 ESD FROM C-V SIGMAA (A) : 0.32
REMARK 3
REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES.
REMARK 3 BOND LENGTHS (A) : 0.007
REMARK 3 BOND ANGLES (DEGREES) : 1.300
REMARK 3 DIHEDRAL ANGLES (DEGREES) : 22.80
REMARK 3 IMPROPER ANGLES (DEGREES) : 0.770
REMARK 3
REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED
REMARK 3
REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA
REMARK 3 MAIN-CHAIN BOND (A**2) : 1.220 ; 1.500
REMARK 3 MAIN-CHAIN ANGLE (A**2) : 2.010 ; 2.000
REMARK 3 SIDE-CHAIN BOND (A**2) : 2.110 ; 2.000
REMARK 3 SIDE-CHAIN ANGLE (A**2) : 3.040 ; 2.500
REMARK 3
REMARK 3 BULK SOLVENT MODELING.
REMARK 3 METHOD USED : FLAT MODEL
REMARK 3 KSOL : 0.36
REMARK 3 BSOL : 38.95
REMARK 3
REMARK 3 NCS MODEL : NULL
REMARK 3
REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT
REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL
REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL
REMARK 3
REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM
REMARK 3 PARAMETER FILE 2 : WATER_REP.PARAM
REMARK 3 PARAMETER FILE 3 : 2059.PARAM
REMARK 3 PARAMETER FILE 4 : SO4.PARAM
REMARK 3 PARAMETER FILE 5 : CIS_PEPTIDE.PARAM
REMARK 3 PARAMETER FILE 6 : NULL
REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP
REMARK 3 TOPOLOGY FILE 2 : NULL
REMARK 3 TOPOLOGY FILE 3 : NULL
REMARK 3 TOPOLOGY FILE 4 : NULL
REMARK 3 TOPOLOGY FILE 5 : NULL
REMARK 3 TOPOLOGY FILE 6 : NULL
REMARK 3
REMARK 3 OTHER REFINEMENT REMARKS: NULL
REMARK 4
REMARK 4 3IL6 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11
REMARK 100
REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 12-AUG-09.
REMARK 100 THE DEPOSITION ID IS D_1000054549.
REMARK 200
REMARK 200 EXPERIMENTAL DETAILS
REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION
REMARK 200 DATE OF DATA COLLECTION : 01-JAN-04
REMARK 200 TEMPERATURE (KELVIN) : 120
REMARK 200 PH : 5.5
REMARK 200 NUMBER OF CRYSTALS USED : 1
REMARK 200
REMARK 200 SYNCHROTRON (Y/N) : N
REMARK 200 RADIATION SOURCE : ROTATING ANODE
REMARK 200 BEAMLINE : NULL
REMARK 200 X-RAY GENERATOR MODEL : ENRAF-NONIUS FR591
REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M
REMARK 200 WAVELENGTH OR RANGE (A) : 1.5418
REMARK 200 MONOCHROMATOR : MIRRORS
REMARK 200 OPTICS : MIRRORS
REMARK 200
REMARK 200 DETECTOR TYPE : IMAGE PLATE
REMARK 200 DETECTOR MANUFACTURER : MAR SCANNER 345 MM PLATE
REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO
REMARK 200 DATA SCALING SOFTWARE : SCALEPACK
REMARK 200
REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19811
REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500
REMARK 200 RESOLUTION RANGE LOW (A) : 25.000
REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 1.000
REMARK 200
REMARK 200 OVERALL.
REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9
REMARK 200 DATA REDUNDANCY : 5.200
REMARK 200 R MERGE (I) : 0.07300
REMARK 200 R SYM (I) : 0.07300
REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 21.5000
REMARK 200
REMARK 200 IN THE HIGHEST RESOLUTION SHELL.
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50
REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.59
REMARK 200 COMPLETENESS FOR SHELL (%) : 99.5
REMARK 200 DATA REDUNDANCY IN SHELL : 4.60
REMARK 200 R MERGE FOR SHELL (I) : 0.36100
REMARK 200 R SYM FOR SHELL (I) : 0.36100
REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.330
REMARK 200
REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH
REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT
REMARK 200 SOFTWARE USED: CNX
REMARK 200 STARTING MODEL: 3IL5
REMARK 200
REMARK 200 REMARK: NULL
REMARK 280
REMARK 280 CRYSTAL
REMARK 280 SOLVENT CONTENT, VS (%): 69.41
REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.02
REMARK 280
REMARK 280 CRYSTALLIZATION CONDITIONS: 25% PEG 3350, 0.2 M AMMONIUM SULFATE,
REMARK 280 0.1 M BIS-TRIS, PH 5.5, VAPOR DIFFUSION, HANGING DROP,
REMARK 280 TEMPERATURE 288K
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY
REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 32 2 1
REMARK 290
REMARK 290 SYMOP SYMMETRY
REMARK 290 NNNMMM OPERATOR
REMARK 290 1555 X,Y,Z
REMARK 290 2555 -Y,X-Y,Z+2/3
REMARK 290 3555 -X+Y,-X,Z+1/3
REMARK 290 4555 Y,X,-Z
REMARK 290 5555 X-Y,-Y,-Z+1/3
REMARK 290 6555 -X,-X+Y,-Z+2/3
REMARK 290
REMARK 290 WHERE NNN -> OPERATOR NUMBER
REMARK 290 MMM -> TRANSLATION VECTOR
REMARK 290
REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS
REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM
REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY
REMARK 290 RELATED MOLECULES.
REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000
REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000
REMARK 290 SMTRY1 2 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 2 0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 45.94733
REMARK 290 SMTRY1 3 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 3 -0.866025 -0.500000 0.000000 0.00000
REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 22.97367
REMARK 290 SMTRY1 4 -0.500000 0.866025 0.000000 0.00000
REMARK 290 SMTRY2 4 0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000
REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 0.00000
REMARK 290 SMTRY2 5 0.000000 -1.000000 0.000000 0.00000
REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 22.97367
REMARK 290 SMTRY1 6 -0.500000 -0.866025 0.000000 0.00000
REMARK 290 SMTRY2 6 -0.866025 0.500000 0.000000 0.00000
REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 45.94733
REMARK 290
REMARK 290 REMARK: NULL
REMARK 300
REMARK 300 BIOMOLECULE: 1
REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM
REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN
REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON
REMARK 300 BURIED SURFACE AREA.
REMARK 350
REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN
REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE
REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS
REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND
REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN.
REMARK 350
REMARK 350 BIOMOLECULE: 1
REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC
REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC
REMARK 350 SOFTWARE USED: PISA
REMARK 350 TOTAL BURIED SURFACE AREA: 6170 ANGSTROM**2
REMARK 350 SURFACE AREA OF THE COMPLEX: 21810 ANGSTROM**2
REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -49.0 KCAL/MOL
REMARK 350 APPLY THE FOLLOWING TO CHAINS: A
REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000
REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000
REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000
REMARK 350 BIOMT1 2 -0.500000 0.866025 0.000000 -357.78900
REMARK 350 BIOMT2 2 0.866025 0.500000 0.000000 206.56958
REMARK 350 BIOMT3 2 0.000000 0.000000 -1.000000 206.76300
REMARK 465
REMARK 465 MISSING RESIDUES
REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE
REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN
REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.)
REMARK 465
REMARK 465 M RES C SSSEQI
REMARK 465 MET A 5
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: CLOSE CONTACTS
REMARK 500
REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC
REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15
REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A
REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375
REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE
REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS.
REMARK 500
REMARK 500 DISTANCE CUTOFF:
REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS
REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS
REMARK 500
REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE
REMARK 500 NH1 ARG A 262 O ASN A 296 2684 2.12
REMARK 500
REMARK 500 REMARK: NULL
REMARK 500
REMARK 500 GEOMETRY AND STEREOCHEMISTRY
REMARK 500 SUBTOPIC: TORSION ANGLES
REMARK 500
REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS:
REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER;
REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE).
REMARK 500
REMARK 500 STANDARD TABLE:
REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2)
REMARK 500
REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI-
REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400
REMARK 500
REMARK 500 M RES CSSEQI PSI PHI
REMARK 500 SER A 15 149.24 -172.04
REMARK 500 GLN A 53 -11.41 -149.27
REMARK 500 ALA A 115 35.69 -149.02
REMARK 500 ALA A 116 -134.03 47.18
REMARK 500 TRP A 153 25.15 -74.07
REMARK 500 THR A 158 -47.32 -147.71
REMARK 500 ALA A 212 116.41 -164.77
REMARK 500 LYS A 214 -10.90 85.20
REMARK 500 ASN A 274 37.06 -161.12
REMARK 500 SER A 282 -126.69 50.24
REMARK 500 SER A 282 -127.26 49.48
REMARK 500
REMARK 500 REMARK: NULL
REMARK 800
REMARK 800 SITE
REMARK 800 SITE_IDENTIFIER: AC1
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE B83 A 401
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC2
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 402
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC3
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 403
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC4
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 404
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC5
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 405
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC6
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 406
REMARK 800
REMARK 800 SITE_IDENTIFIER: AC7
REMARK 800 EVIDENCE_CODE: SOFTWARE
REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE SO4 A 407
REMARK 900
REMARK 900 RELATED ENTRIES
REMARK 900 RELATED ID: 3IL3 RELATED DB: PDB
REMARK 900 STRUCTURE OF HAEMOPHILUS INFLUENZAE FABH
REMARK 900 RELATED ID: 3IL4 RELATED DB: PDB
REMARK 900 STRUCTURE OF E. FAECALIS FABH IN COMPLEX WITH ACETYL COA
REMARK 900 RELATED ID: 3IL5 RELATED DB: PDB
REMARK 900 STRUCTURE OF E. FAECALIS FABH IN COMPLEX WITH 2-({4-BROMO-3-
REMARK 900 [(DIETHYLAMINO)SULFONYL]BENZOYL}AMINO)BENZOIC ACID
REMARK 900 RELATED ID: 3IL7 RELATED DB: PDB
REMARK 900 CRYSTAL STRUCTURE OF S. AUREUS FABH
REMARK 900 RELATED ID: 3IL9 RELATED DB: PDB
REMARK 900 STRUCTURE OF E. COLI FABH
DBREF 3IL6 A 5 325 UNP Q820T1 FABH_ENTFA 1 321
SEQADV 3IL6 ALA A 36 UNP Q820T1 ASP 32 ENGINEERED MUTATION
SEQADV 3IL6 ALA A 37 UNP Q820T1 GLU 33 ENGINEERED MUTATION
SEQADV 3IL6 THR A 192 UNP Q820T1 ALA 188 ENGINEERED MUTATION
SEQRES 1 A 321 MET LYS ASN TYR ALA ARG ILE SER CYS THR SER ARG TYR
SEQRES 2 A 321 VAL PRO GLU ASN CYS VAL THR ASN HIS GLN LEU SER GLU
SEQRES 3 A 321 MET MET ASP THR SER ALA ALA TRP ILE HIS SER ARG THR
SEQRES 4 A 321 GLY ILE SER GLU ARG ARG ILE VAL THR GLN GLU ASN THR
SEQRES 5 A 321 SER ASP LEU CYS HIS GLN VAL ALA LYS GLN LEU LEU GLU
SEQRES 6 A 321 LYS SER GLY LYS GLN ALA SER GLU ILE ASP PHE ILE LEU
SEQRES 7 A 321 VAL ALA THR VAL THR PRO ASP PHE ASN MET PRO SER VAL
SEQRES 8 A 321 ALA CYS GLN VAL GLN GLY ALA ILE GLY ALA THR GLU ALA
SEQRES 9 A 321 PHE ALA PHE ASP ILE SER ALA ALA SCY SER GLY PHE VAL
SEQRES 10 A 321 TYR ALA LEU SER MET ALA GLU LYS LEU VAL LEU SER GLY
SEQRES 11 A 321 ARG TYR GLN THR GLY LEU VAL ILE GLY GLY GLU THR PHE
SEQRES 12 A 321 SER LYS MET LEU ASP TRP THR ASP ARG SER THR ALA VAL
SEQRES 13 A 321 LEU PHE GLY ASP GLY ALA ALA GLY VAL LEU ILE GLU ALA
SEQRES 14 A 321 ALA GLU THR PRO HIS PHE LEU ASN GLU LYS LEU GLN ALA
SEQRES 15 A 321 ASP GLY GLN ARG TRP THR ALA LEU THR SER GLY TYR THR
SEQRES 16 A 321 ILE ASN GLU SER PRO PHE TYR GLN GLY HIS LYS GLN ALA
SEQRES 17 A 321 SER LYS THR LEU GLN MET GLU GLY ARG SER ILE PHE ASP
SEQRES 18 A 321 PHE ALA ILE LYS ASP VAL SER GLN ASN ILE LEU SER LEU
SEQRES 19 A 321 VAL THR ASP GLU THR VAL ASP TYR LEU LEU LEU HIS GLN
SEQRES 20 A 321 ALA ASN VAL ARG ILE ILE ASP LYS ILE ALA ARG LYS THR
SEQRES 21 A 321 LYS ILE SER ARG GLU LYS PHE LEU THR ASN MET ASP LYS
SEQRES 22 A 321 TYR GLY ASN THR SER ALA ALA SER ILE PRO ILE LEU LEU
SEQRES 23 A 321 ASP GLU ALA VAL GLU ASN GLY THR LEU ILE LEU GLY SER
SEQRES 24 A 321 GLN GLN ARG VAL VAL LEU THR GLY PHE GLY GLY GLY LEU
SEQRES 25 A 321 THR TRP GLY SER LEU LEU LEU THR LEU
MODRES 3IL6 SCY A 117 CYS S-ACETYL-CYSTEINE
HET SCY A 117 9
HET B83 A 401 33
HET SO4 A 402 5
HET SO4 A 403 5
HET SO4 A 404 5
HET SO4 A 405 5
HET SO4 A 406 5
HET SO4 A 407 5
HETNAM SCY S-ACETYL-CYSTEINE
HETNAM B83 2-[({4-[(3R,5S)-3,5-DIMETHYLPIPERIDIN-1-YL]-3-
HETNAM 2 B83 PHENOXYPHENYL}CARBONYL)AMINO]BENZOIC ACID
HETNAM SO4 SULFATE ION
HETSYN B83 2-({4-[(3R,5S)-3,5-DIMETHYLPIPERIDIN-1-YL]-3-
HETSYN 2 B83 PHENOXYBENZOYL}AMINO)BENZOIC ACID
FORMUL 1 SCY C5 H9 N O3 S
FORMUL 2 B83 C27 H28 N2 O4
FORMUL 3 SO4 6(O4 S 2-)
FORMUL 9 HOH *112(H2 O)
HELIX 1 1 ASN A 25 MET A 32 1 8
HELIX 2 2 SER A 35 GLY A 44 1 10
HELIX 3 3 ASN A 55 GLY A 72 1 18
HELIX 4 4 GLN A 74 ILE A 78 5 5
HELIX 5 5 SER A 94 ILE A 103 1 10
HELIX 6 6 ALA A 115 SCY A 117 5 3
HELIX 7 7 SER A 118 SER A 133 1 16
HELIX 8 8 THR A 146 LEU A 151 5 6
HELIX 9 9 THR A 158 PHE A 162 5 5
HELIX 10 10 GLY A 188 THR A 192 5 5
HELIX 11 11 GLU A 219 SER A 237 1 19
HELIX 12 12 THR A 240 VAL A 244 5 5
HELIX 13 13 ASN A 253 LYS A 265 1 13
HELIX 14 14 SER A 267 PHE A 271 5 5
HELIX 15 15 ASN A 274 TYR A 278 5 5
HELIX 16 16 THR A 281 ALA A 283 5 3
HELIX 17 17 ALA A 284 ASN A 296 1 13
SHEET 1 A 5 TYR A 8 TYR A 17 0
SHEET 2 A 5 GLY A 165 ALA A 174 -1 O ALA A 174 N TYR A 8
SHEET 3 A 5 GLY A 139 GLU A 145 -1 N GLY A 139 O ILE A 171
SHEET 4 A 5 PHE A 80 ALA A 84 1 N LEU A 82 O LEU A 140
SHEET 5 A 5 PHE A 109 ILE A 113 1 O ILE A 113 N VAL A 83
SHEET 1 B 2 CYS A 22 THR A 24 0
SHEET 2 B 2 GLU A 47 ARG A 49 -1 O ARG A 48 N VAL A 23
SHEET 1 C 4 PHE A 179 ALA A 186 0
SHEET 2 C 4 THR A 317 THR A 324 -1 O TRP A 318 N GLN A 185
SHEET 3 C 4 ARG A 306 GLY A 313 -1 N VAL A 307 O LEU A 323
SHEET 4 C 4 TYR A 246 LEU A 249 1 N LEU A 248 O VAL A 308
SHEET 1 D 2 LEU A 194 THR A 195 0
SHEET 2 D 2 GLN A 217 MET A 218 -1 O GLN A 217 N THR A 195
LINK C ALA A 116 N SCY A 117 1555 1555 1.33
LINK C SCY A 117 N SER A 118 1555 1555 1.34
CISPEP 1 MET A 92 PRO A 93 0 0.54
CISPEP 2 GLY A 315 LEU A 316 0 -0.09
SITE 1 AC1 15 ARG A 42 SCY A 117 SER A 157 LEU A 161
SITE 2 AC1 15 GLY A 220 ARG A 221 ILE A 223 PHE A 224
SITE 3 AC1 15 HIS A 250 ALA A 252 ILE A 256 ASN A 280
SITE 4 AC1 15 PHE A 312 GLY A 313 HOH A 386
SITE 1 AC2 7 ARG A 10 TRP A 38 ALA A 174 GLU A 175
SITE 2 AC2 7 THR A 176 HIS A 178 SO4 A 403
SITE 1 AC3 7 LYS A 6 ARG A 10 ASP A 33 THR A 34
SITE 2 AC3 7 ARG A 156 GLU A 175 SO4 A 402
SITE 1 AC4 3 LYS A 259 ARG A 262 HOH A 329
SITE 1 AC5 3 ARG A 221 LYS A 259 HOH A 362
SITE 1 AC6 5 THR A 273 ASN A 274 MET A 275 ASP A 276
SITE 2 AC6 5 HOH A 336
SITE 1 AC7 3 ARG A 49 HOH A 375 HOH A 397
CRYST1 119.263 119.263 68.921 90.00 90.00 120.00 P 32 2 1 6
ORIGX1 1.000000 0.000000 0.000000 0.00000
ORIGX2 0.000000 1.000000 0.000000 0.00000
ORIGX3 0.000000 0.000000 1.000000 0.00000
SCALE1 0.008385 0.004841 0.000000 0.00000
SCALE2 0.000000 0.009682 0.000000 0.00000
SCALE3 0.000000 0.000000 0.014509 0.00000